Dr. Hans-Ulrich Klein received his PhD in Biomedical Informatics and Biomathematics from the University of Münster, Germany, where he worked on models and algorithms to analyze and integrate epigenomic and transcriptomic data. Following an emerging interest in epigenetic mechanisms of aging and neurodegeneration, he joined the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital and Harvard Medical School as a research fellow in Dr. Philip De Jager’s laboratory, and subsequently continued his research fellowship here at the Taub Institute, prior to being recruited as a faculty member. Dr. Klein’s current research focuses on the interaction between the epigenome, transcriptome, genetic risk variants and neuropathologies in different cell types of the central nervous system, with the aim of understanding the pathogenesis of neurological diseases.